Ireland Inhalers Market, By Product (Dry Powder Inhalers, Metered Dose Inhalers, and Nebulizers), By Technology (Manual Operated Inhaler Devices, Digitally Operated Inhaler Devices), Disease Indication (Asthma, Chronic Obstructive Pulmonary Diseases, Pulmonary Arterial Hypertension, and Others), By Region, Competition, Forecast and Opportunities, 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationIreland Inhalers Market, By Product (Dry Powder Inhalers, Metered Dose Inhalers, and Nebulizers), By Technology (Manual Operated Inhaler Devices, Digitally Operated Inhaler Devices), Disease Indication (Asthma, Chronic Obstructive Pulmonary Diseases, Pulmonary Arterial Hypertension, and Others), By Region, Competition, Forecast and Opportunities, 2028
For instance, according to Center for Disease Control and Prevention (CDC), during the coronavirus pandemic individuals suffering from moderate to severe asthma were at a greater risk of falling ill with acute respiratory disease.
Asthma is a major non-communicable disease that affects both adults and childrens. The chronic obstructive pulmonary disease (COPD) was responsible for about 3.23 million deaths in the same year.
One of the key drivers of growth is increasing focus on the development of inhalers and a rise in initiatives by key market players for research and development, which are driving the demand for Ireland inhalers market.
The National Institute of Health estimates that among adults in Ireland, the prevalence of the four major chronic disease categories is 5.2% for diabetes, 9.4% for cardiovascular disease (CVD), and 9.8% for chronic obstructive pulmonary disease (COPD).
Furthermore, the ongoing research and development of technology in the development of therapy for asthma treatment using inhalers is expected to aid the growth of the Ireland inhalers market in the forecast period, 2024-2028. Moreover, the government also supports the idea by increasing investment in the pharmaceutical sector and the pharmaceutical companies to enforce manufacturers for taking interest in research and development of advanced treatment in Ireland to bolster the growth of Ireland inhalers market.
Rising Prevalence of Chronic Diseases
For instance, according to WHO, asthma affected about 262 million people and 455,000 people succumbed to the disease in 2019. Majority of asthma related deaths occur in low and lower middle-income countries where underdiagnosis and undertreatment are common
.
Increasing Prevalence of Respiratory Diseases
According to Irish Thoracic Society, respiratory disease led to 5,720 deaths and 14.3% of all inpatient hospitalizations in Ireland in 2016. Respiratory disease causes almost one in 5 deaths in Ireland. Lung cancer accounted for 1,864 deaths (20.6% of cancer deaths) in Ireland in 2016. This was an increase of 11.8% (1,668) on the 2007 figure.
Advancements in Research and Development
According to clinicaltrials.gov, 1685 studies are found for inhalers which provides a biggest support in the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD).
Increasing Air Pollution Triggering Asthma Cases
. For instance, according to research, the air pollution from traffic, nitrogen dioxide, and second-hand smoking (SHS) are all substantial risk factors for the development of asthma in children
Download Free Sample Report
Market Segmentation
The Ireland inhalers market is segmented by product, technology, disease indication, regional distribution, and competitional landscape. Based on product, the market is further bifurcated into dry powder inhalers, metered dose inhalers, and nebulizers. Based on technology, the market is bifurcated into manual operated inhaler devices and digitally operated inhaler devices. Based on disease indication, the market is bifurcated into asthma, chronic obstructive pulmonary diseases, pulmonary arterial hypertension, and others.
Market Players
GlaxoSmithKline Ireland, AstraZeneca Ireland Limited, Propeller Health, Teva Pharmaceuticals Ireland Limited, and Novartis Ireland Limited are some of the leading companies operating in the Ireland inhalers market.
| Attribute | Details |
| Base Year | 2022 |
| Historical Years | 2018 – 2022 |
| Estimated Year | 2022E |
| Forecast Period | 2023F – 2028F |
| Quantitative Units | Revenue in USD Million, Volume in Units, and CAGR for 2017-2021 and 2022E-2028F |
| Report Coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | Product Technology Disease Indication Region Company |
| Region Scope | Northern Ireland, North-West, West, Midland East, Dublin, Shannon, South-East, Cork-Kerry |
| Key Companies Profiled | GlaxoSmithKline Ireland, AstraZeneca Ireland Limited, Propeller Health, Teva Pharmaceuticals Ireland Limited, Novartis Ireland Limited |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy